In vitro effect of indomethacin and interferon-α on Th1 and Th2 cytokine synthesis in patients with chronic hepatitis C

Cytokine

Volumn 26, Issue 3, 2004, Pages 95-101

  Andreone, Pietro ^a   Gramenzi, Annagiulia ^a   Loggi, Elisabetta ^a   Favarelli, Laura ^a   Cursaro, Carmela ^a   Margotti, Marzia ^a   Biselli, Maurizio ^a   Lorenzini, Stefania ^a   Bernardi, Mauro ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Hepatitis C; Immune response; Indomethacin; Interferon ; Th1; Th2

Indexed keywords

2',5' OLIGOADENYLATE SYNTHETASE; ALPHA INTERFERON; ALPHAN1 INTERFERON; GAMMA INTERFERON; INDOMETACIN; INDOMETACIN MEGLUMINE; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; NONSTEROID ANTIINFLAMMATORY AGENT; VIRUS PROTEIN;

ADULT; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME SYNTHESIS; FEMALE; HEPATITIS C; HUMAN; HUMAN CELL; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIVIRAL AGENTS; CYTOKINES; HEPATITIS C, CHRONIC; HUMANS; INDOMETHACIN; INTERFERON-ALPHA; MALE; MIDDLE AGED; TH1 CELLS; TH2 CELLS;

HEPATITIS C VIRUS;

EID: 2342531014     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2003.08.014     Document Type: Article

References (22)

1. Alberti A., Chemello L., Benvegnù L. Natural history of hepatitis C. J Hepatol. 31:(Suppl 1):1999;17-24
2. Mosmann T.R., Cherwinski H., Bond M.W., Giedlin M.A., Coffman R.L. Two types of murine helper T cell clone I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol. 136:1986;2348-2357
3. Koziel M.J. Cytokines in viral hepatitis. Semin Liver Dis. 2:1999;157-168
4. Tsai S.L., Liaw Y.F., Chen M.H., Huang C.Y., Kuo G. Detection of type 2-like helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity. Hepatology. 25:1997;449-457
5. Sarih M., Bouchrit N., Benslimane A. Different cytokine profiles of peripheral blood mononuclear cells from patients with persistent and self-limited hepatitis C virus infection. Immunol Lett. 74:2000;117-120
6. Di Bisceglie A.M., Hoofnagle J.H. Optimal therapy of hepatitis C. Hepatology. 36:(Suppl 1):2002;s121-s127
7. Giambartolomei S., Artini M., Almerighi C., Moavero S.A., Levrero M., Balsano C. Non steroidal anti-inflammatory drug metabolism potentiates interferon alpha signaling by increasing STAT1 phosphorylation. Hepatology. 30:1999;510-516
8. Andreone P., Cursaro C., Gramenzi A., Buzzi A., Miniero R., Bernardi M., et al. Indomethacin increases 2′, 5′-oligoadenylate synthetase release by cultured liver tissue of patients with HCV chronic active hepatitis. Int Hepatol Commun. 2:1994;289-294
9. Andreone P., Cursaro C., Gramenzi A., Buzzi A., Miniero R., Sprovieri G., et al. Indomethacin enhances 2′, 5′-oligoadenylate synthetase in patients hepatitis B and C virus chronic active hepatitis. J Hepatol. 21:1994;984-988
10. Kapicioglu S., Sari M., Kaynar K., Baki A., Ozoran Y. The effect of indomethacin on hepatitis B virus replication in chronic healthy carriers. Scand J Gastroenterol. 35:2000;957-959
11. Andreone P., Cursaro C., Gramenzi A., Fiorino S., Di Giammarino L., Miniero R., et al. Interferon alpha plus ketoprofen or interferon alpha plus ribavirin in chronic hepatitis C non-responders to interferon alpha alone: results of a pilot study. Ital J Gastroenterol Hepatol. 31:1999;688-694
12. Andreone P., Cursaro C., Gramenzi A., Margotti M., Ferri E., Talarico S., et al. In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with chronic hepatitis C. J Viral Hepat. 8:2001;194-201
13. Platanias L.C., Fish E.N. Signaling pathways activated by interferons. Exp Hematol. 27:1999;1583-1592
14. Hannigan G.E., Williams B.R.G. Signal transduction by interferon - a through arachidonic acid metabolism. Science. 251:1991;204-207
15. Zarski J.P., Maynard-Muet M., Chousterman S., Baud M., Barnoud R., Abergel A., et al. Tenoxicam, a non-steroidal anti-inflammatory drug, is unable to increase the response rate in patients with chronic hepatitis C treated by alpha interferon. Hepatology. 27:1998;862-867
16. Fabris P., Tositti G., Negro F., Marranconi F., Infantolino D., Rassu M., et al. Interferon alfa-2b alone or in combination with ketoprofen as treatment for interferon-naive chronic hepatitis C patients. Aliment Pharmacol Ther. 13:1999;1329-1334
17. Muñoz A.E., Levi D., Podestà A., Gorin J.M., Gonzalez J., Bartellini M.A., et al. Interferon-α2b combined with daily ketoprofen administration improves virological response in chronic hepatitis C: a prospective and rondomized trial. Gut. 46:2000;427-431
18. Andreone P., Gramenzi A., Cursaro C., Biselli M., Lorenzini S., Loggi E., et al. Interferon-a combined with ketoprofen as treatment of naive patients with chronic hepatitis C: a randomized controlled trial. J Viral Hepat. 10:2003;306-309
19. Biron C.A. Cytokines in the generation of immune response to and resolution of virus infection. Curr Opin Immunol. 6:1994;530-538
20. Kamal S.M., Rasenack J.W., Bianchi L., Al Tawil A., El Sayed Khalifa K., Peter T., et al. Acute hepatitis C without and with schistosomiasis: correlation with hepatitis C-specific CD4(+) T-cell and cytokine response. Gastroenterology. 121:2001;646-656
21. Shapiro S., Gershtein V., Elias N., Zuckerman E., Salman N., Lahat N. mRNA cytokine profile in peripheral blood cells from chronic hepatitis C virus (HCV)-infected patients: effects of interferon-alpha treatment. Clin Exp Immunol. 114:1998;55-60
22. Cramp M.E., Rossol S., Chokshi S., Carucci P., Williams R., Naoumov N.V. Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C. Gastroenterology. 118:2000;346-355